Biobank Clinical Genetics Maastricht for Genetic Disease Research

What this Trial Is About

This research aims to collect coded biological samples and clinical information from patients with genetic diseases to support future studies. The goal is to identify new gene mutations and explore potential treatment options. The study is observational and involves patients at the Maastricht University Medical Center's Clinical Genetics department. Participants provide biological material that will be stored for genetic research in five key areas: cardiogenetics, intellectual disability and rare diseases, oncogenetics, dermatogenetics, and reproductive genetics. The study utilizes biobanking to preserve samples for future analysis. Genes will be sequenced and compared over an expected average period of six months to discover unknown gene functions. During the study, participants will undergo genetic diagnostics involving the collection of biological samples. Researchers will evaluate genetic data and compare gene sequences as the primary outcome. Participation involves providing consent and samples, with no interventional treatment given. The study will continue through 2035, allowing for long-term research and data collection.

Biobank Clinical Genetics Maastricht (KG01)